Literature DB >> 25135685

Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection.

Melinda M Pettigrew1, Laura R Marks2, Yong Kong3, Janneane F Gent4, Hazeline Roche-Hakansson2, Anders P Hakansson5.   

Abstract

Streptococcus pneumoniae is a leading cause of infectious disease globally. Nasopharyngeal colonization occurs in biofilms and precedes infection. Prior studies have indicated that biofilm-derived pneumococci are avirulent. However, influenza A virus (IAV) infection releases virulent pneumococci from biofilms in vitro and in vivo. Triggers of dispersal include IAV-induced changes in the nasopharynx, such as increased temperature (fever) and extracellular ATP (tissue damage). We used whole-transcriptome shotgun sequencing (RNA-seq) to compare the S. pneumoniae transcriptome in biofilms, bacteria dispersed from biofilms after exposure to IAV, febrile-range temperature, or ATP, and planktonic cells grown at 37°C. Compared with biofilm bacteria, actively dispersed S. pneumoniae, which were more virulent in invasive disease, upregulated genes involved in carbohydrate metabolism. Enzymatic assays for ATP and lactate production confirmed that dispersed pneumococci exhibited increased metabolism compared to those in biofilms. Dispersed pneumococci also upregulated genes associated with production of bacteriocins and downregulated colonization-associated genes related to competence, fratricide, and the transparent colony phenotype. IAV had the largest impact on the pneumococcal transcriptome. Similar transcriptional differences were also observed when actively dispersed bacteria were compared with avirulent planktonic bacteria. Our data demonstrate complex changes in the pneumococcal transcriptome in response to IAV-induced changes in the environment. Our data suggest that disease is caused by pneumococci that are primed to move to tissue sites with altered nutrient availability and to protect themselves from the nasopharyngeal microflora and host immune response. These data help explain pneumococcal virulence after IAV infection and have important implications for studies of S. pneumoniae pathogenesis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25135685      PMCID: PMC4249342          DOI: 10.1128/IAI.02225-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  82 in total

1.  Newborn vitamin A supplementation does not affect nasopharyngeal carriage of Streptococcus pneumoniae in Bangladeshi infants at age 3 months.

Authors:  Christian L Coles; Alain Labrique; Samir K Saha; Hasmot Ali; Hassan Al-Emran; Mahbubur Rashid; Parul Christian; Keith P West; Rolf Klemm
Journal:  J Nutr       Date:  2011-08-10       Impact factor: 4.798

2.  LuxS mediates iron-dependent biofilm formation, competence, and fratricide in Streptococcus pneumoniae.

Authors:  Claudia Trappetti; Adam J Potter; Adrienne W Paton; Marco R Oggioni; James C Paton
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

Review 3.  Recognition of Streptococcus pneumoniae by the innate immune system.

Authors:  Uwe Koppe; Norbert Suttorp; Bastian Opitz
Journal:  Cell Microbiol       Date:  2012-02-08       Impact factor: 3.715

4.  The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39.

Authors:  Jorge E Vidal; Herbert P Ludewick; Rebekah M Kunkel; Dorothea Zähner; Keith P Klugman
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

5.  Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States.

Authors:  Daniel M Weinberger; Lone Simonsen; Richard Jordan; Claudia Steiner; Mark Miller; Cécile Viboud
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

6.  Coupled nucleotide and mucin hypersecretion from goblet-cell metaplastic human airway epithelium.

Authors:  Seiko F Okada; Liqun Zhang; Silvia M Kreda; Lubna H Abdullah; C William Davis; Raymond J Pickles; Eduardo R Lazarowski; Richard C Boucher
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-08       Impact factor: 6.914

7.  Invasive bacterial infections in relation to influenza outbreaks, 2006-2010.

Authors:  Diana Tasher; Michal Stein; Eric A F Simões; Tamar Shohat; Michal Bromberg; Eli Somekh
Journal:  Clin Infect Dis       Date:  2011-10-21       Impact factor: 9.079

8.  The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya.

Authors:  Osman Abdullahi; Angela Karani; Caroline C Tigoi; Daisy Mugo; Stella Kungu; Eva Wanjiru; Jane Jomo; Robert Musyimi; Marc Lipsitch; J Anthony G Scott
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

9.  Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production.

Authors:  Carlos J Sanchez; Nikhil Kumar; Anel Lizcano; Pooja Shivshankar; Julie C Dunning Hotopp; James H Jorgensen; Hervé Tettelin; Carlos J Orihuela
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

10.  A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae.

Authors:  Alessandro Bidossi; Laura Mulas; Francesca Decorosi; Leonarda Colomba; Susanna Ricci; Gianni Pozzi; Josef Deutscher; Carlo Viti; Marco Rinaldo Oggioni
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

View more
  50 in total

1.  Directed vaccination against pneumococcal disease.

Authors:  Yi Li; Andrew Hill; Marie Beitelshees; Shuai Shao; Jonathan F Lovell; Bruce A Davidson; Paul R Knight; Anders P Hakansson; Blaine A Pfeifer; Charles H Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

2.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

3.  Standardization of Pneumococcal Biofilm Release to PncO Expression, a Predictive Measurement of Virulence.

Authors:  A Hill; M Beitelshees; B A Pfeifer; C H Jones
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

Review 4.  Close Encounters of the Viral Kind: Cross-Kingdom Synergies at the Host-Pathogen Interface.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  Bioessays       Date:  2019-11-06       Impact factor: 4.345

Review 5.  The potential impact of coinfection on antimicrobial chemotherapy and drug resistance.

Authors:  Ruthie B Birger; Roger D Kouyos; C Jessica E Metcalf; Ted Cohen; Emily C Griffiths; Silvie Huijben; Michael J Mina; Victoriya Volkova; Bryan Grenfell
Journal:  Trends Microbiol       Date:  2015-05-29       Impact factor: 17.079

Review 6.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

Review 7.  Streptococcus pneumoniae: Invasion and Inflammation.

Authors:  Allister J Loughran; Carlos J Orihuela; Elaine I Tuomanen
Journal:  Microbiol Spectr       Date:  2019-03

Review 8.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 9.  Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.

Authors:  Amrita Patil; Rajashri Banerji; Poonam Kanojiya; Sunil D Saroj
Journal:  Pathog Glob Health       Date:  2021-04-14       Impact factor: 2.894

10.  Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.

Authors:  Christopher J Greene; Laura R Marks; John C Hu; Ryan Reddinger; Lorrie Mandell; Hazeline Roche-Hakansson; Natalie D King-Lyons; Terry D Connell; Anders P Hakansson
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.